Belite Bio Adr Stock Analysis

Belite Stock Analysis Notes

About 59.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.1. Belite Bio ADR had not issued any dividends in recent years. Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd. Belite Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. For more info on Belite Bio ADR please contact YuHsin MBA at 858 246 6240 or go to https://www.belitebio.com.

Belite Bio ADR Investment Alerts

Belite Bio ADR Upcoming and Recent Events

Belite Largest EPS Surprises

View All Earnings Estimates

Belite Bio Environmental, Social, and Governance (ESG) Scores

Belite Stock Institutional Investors

Note, although Belite Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Belite Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.08 B.

Belite Profitablity

Management Efficiency

Belite Bio ADR has return on total asset (ROA) of (0.2558) % which means that it has lost $0.2558 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4004) %, meaning that it created substantial loss on money invested by shareholders. Belite Bio's management efficiency ratios could be used to measure how well Belite Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of November 30, 2024, Return On Tangible Assets is expected to decline to -0.36. In addition to that, Return On Capital Employed is expected to decline to -0.37. At present, Belite Bio's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.04, whereas Net Tangible Assets are forecasted to decline to (14.3 M).

Technical Drivers

As of the 30th of November, Belite Bio shows the Downside Deviation of 4.42, mean deviation of 2.3, and Risk Adjusted Performance of 0.0968. Belite Bio ADR technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Belite Bio ADR information ratio, as well as the relationship between the value at risk and expected short fall to decide if Belite Bio ADR is priced correctly, providing market reflects its regular price of 63.26 per share. Given that Belite Bio has jensen alpha of 0.3795, we suggest you to validate Belite Bio ADR's prevailing market performance to make sure the company can sustain itself at a future point.

Belite Bio ADR Price Movement Analysis

Belite Bio Outstanding Bonds

Belite Bio Predictive Daily Indicators

Belite Bio Corporate Filings

Belite Bio Forecast Models

Belite Bio's time-series forecasting models are one of many Belite Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Belite Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Belite Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Belite shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Belite Bio. By using and applying Belite Stock analysis, traders can create a robust methodology for identifying Belite entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Belite analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Belite analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Belite Bio ADR stock analysis indicators help investors evaluate how Belite Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Belite Bio shares will generate the highest return on investment. By understating and applying Belite Bio stock analysis, traders can identify Belite Bio position entry and exit signals to maximize returns.

When running Belite Bio's price analysis, check to measure Belite Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Belite Bio is operating at the current time. Most of Belite Bio's value examination focuses on studying past and present price action to predict the probability of Belite Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Belite Bio's price. Additionally, you may evaluate how the addition of Belite Bio to your portfolios can decrease your overall portfolio volatility.